| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.45B | -3.3% |
| Gross Profit | $832.0M | -7.0% |
| R&D Expense | $12.0M | -7.7% |
| SG&A Expense | $289.0M | -9.1% |
| Operating Income | $458.0M | -20.6% |
| Interest Expense | $125.0M | -20.4% |
| Pre-tax Income | $308.0M | -17.6% |
| Income Tax | -$192.0M | -370.4% |
| Net Income | $497.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.0M | -28.1% |
| Accounts Receivable | $377.0M | -40.3% |
| Inventory | $1.28B | +21.9% |
| Current Assets | $1.96B | -4.3% |
| Total Assets | $6.31B | +5.3% |
| Current Liabilities | $850.0M | +3.4% |
| Long-term Debt | $2.46B | -3.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $598.0M | -19.2% |
| Investing Cash Flow | -$415.0M | -54.3% |
| Financing Cash Flow | -$250.0M | +71.5% |
| +73.8% |
| EPS (Basic) | $3.21 | +70.7% |
| EPS (Diluted) | $3.16 | +74.6% |
| Total Liabilities |
| $3.90B |
| -1.1% |
| Stockholders' Equity | $2.36B | +18.2% |